Plus   Neg

Texas Instruments Q3 Results Beat Street View, Outlook Strong

Texas Instruments Inc. (TXN) on Tuesday reported a third-quarter profit and revenues that trumped Wall Street analysts' expectations. The company also issued a financial guidance for the fourth quarter, which is expected to beat current estimates.

Dallas, Texas-based Texas Instrument's third-quarter profit dropped to $1.35 billion or $1.45 per share from $1.43 billion or $1.49 per share last year. Analysts polled by Thomson Reuters expected the company to earn $1.27 per share. Analysts' estimates typically exclude special items.

Revenue for the quarter rose 1.3% to $3.82 billion from $3.77 billion last year. Analysts had a consensus revenue estimate of $3.43 billion for the quarter.

Analog revenue grew 7% and Embedded Processing declined 10%.

Looking forward to the fourth quarter, the company expects revenues of $3.41 billion to $3.69 billion and earnings between $1.20 and $1.40 per share. Analysts currently estimate earnings of $1.19 per share on revenues of $3.33 billion.

TXN closed Tuesday's trading at $150.83, up $0.07 or 0.05%, on the Nasdaq. The stock further gained $1.67 or 1.11% in the after-hours trading.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Data giant S&P Global Inc. has agreed to acquire information and analytics company IHS Markit Ltd. in an all-stock deal, the two companies said Monday. The deal values IHS Markit at an enterprise value of $44 billion, including $4.8 billion of net debt. Shares of IHS Markit are gaining almost 6 percent following the news. The deal is the biggest in 2020. Moderna, Inc. (MRNA) said it will apply for an Emergency Use approval of its Covid vaccine as the latest study showed that the vaccine candidate is 94.1% effective to prevent Covid-19. The company said there have been no serious safety concerns identified. The company will file for an Emergency... Vegpro International is recalling Fresh Attitude baby spinach citing potential to be contaminated with Salmonella, according to the U.S. Food and Drug Administration. The recall involves Fresh Attitude baby spinach of 5oz with best before dates of December 4 & 5; and 11oz with best before date of December 4.
Follow RTT